ALK Expression Defines a Distinct Group of T/Null Lymphomas (“ALK Lymphomas”) with a Wide Morphological Spectrum
Brunangelo Falini(University of Perugia), Leonardo Flenghi(University of Perugia), Marco Paulli(University of Milan), Marco Fizzotti(University of Perugia), Barbara Ugolini(University of Perugia), Antonino Carbone(Centro di Riferimento Oncologico), Fabio Menestrina(University of Verona), Pier Giuseppe Pelicci(University of Milan), Roberta Pacini(University of Foggia), Monia Billi(University of Perugia), Umberto Magrini(University of Pavia), Barbara Bigerna(University of Perugia), Roberto Giardini(Fondazione IRCCS Istituto Nazionale dei Tumori), Georges Delsol(Hôpital Purpan), Alessandra Pucciarini(University of Perugia), Stefano A. Pileri(University of Bologna), Alessandra Mezzelani(Fondazione IRCCS Istituto Nazionale dei Tumori), Silvana Pilotti(Fondazione IRCCS Istituto Nazionale dei Tumori), Karen Pulford(Centre National de la Recherche Scientifique)
Cited by 275
Related Papers
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
|Nature reviews. Cancer|2006|2.2k
Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal Karyotype
|New England Journal of Medicine|2005|1.9k
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k